Last reviewed · How we verify

Suprascapular and median nerve blocks

Ottawa Hospital Research Institute · FDA-approved active Small molecule

Suprascapular and median nerve blocks are regional anesthesia techniques that deliver local anesthetic to specific peripheral nerves to block pain sensation in targeted areas of the shoulder and hand.

Suprascapular and median nerve blocks are regional anesthesia techniques that deliver local anesthetic to specific peripheral nerves to block pain sensation in targeted areas of the shoulder and hand. Used for Shoulder pain and rotator cuff pathology (suprascapular block), Hand and wrist pain (median nerve block), Perioperative anesthesia for shoulder and hand surgery.

At a glance

Generic nameSuprascapular and median nerve blocks
Also known asBupivacaine, kenalog
SponsorOttawa Hospital Research Institute
ModalitySmall molecule
Therapeutic areaPain Management / Regional Anesthesia
PhaseFDA-approved

Mechanism of action

These are procedural interventions rather than pharmaceutical drugs. Suprascapular nerve blocks anesthetize the nerve supplying the shoulder joint and rotator cuff, while median nerve blocks target the nerve providing sensation to the palm and fingers. Local anesthetic is injected near these nerves under ultrasound or anatomical guidance to provide temporary pain relief and enable surgical or therapeutic procedures without systemic anesthesia.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: